Calithera Biosciences (CALA) Expected to Announce Earnings on Wednesday

Calithera Biosciences (NASDAQ:CALA) is projected to release its resultson Wednesday, May 13th. Analysts expect Calithera Biosciences to post earnings of ($4.8020) per share for the quarter.

Calithera Biosciences Trading Up 100.0%

Calithera Biosciences stock opened at $0.00 on Tuesday. The company has a market cap of $772.00, a price-to-earnings ratio of 0.00 and a beta of -1.05. Calithera Biosciences has a 52-week low of $0.00 and a 52-week high of $0.00.

About Calithera Biosciences

Calithera Biosciences, Inc is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The company is focused on the discovery and development of small molecule inhibitors that target metabolic pathways critical to the growth and survival of cancer cells. By disrupting tumor metabolism, Calithera aims to create novel therapeutic options for patients with solid tumors and hematologic malignancies.

The company’s pipeline includes lead candidates such as telaglenastat (CB-839), a glutaminase inhibitor being evaluated in multiple Phase 2 trials across various tumor types, and CB-1158, an arginase inhibitor designed to reprogram the tumor microenvironment and enhance anti-tumor immunity.